The Company recently confirmed that the preliminary HLA prevalence, safety, and immune response data in FLAMINGO-01 patients is trending as expected in both HLA-A*02 and non-HLA-A*02 arms. The non-HLA ...

Collaboration to apply Lunit’s AI technologies across NCI’s broad spectrum of cancer studies, aiming to accelerate personalized cancer ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.

An episode of the "Joe Rogan Experience" podcast, seen by more than 10 million, appears to have reignited interest in the ...